April 2, 2007 — Cordis Corp. has announced today the start of the pivotal trial for the ExoSeal Vascular Closure Device. The ECLIPSE Trial is a multicenter, non-blinded, randomized study designed to measure the safety and efficacy of the ExoSeal Vascular Closure Device versus manual compression to close vascular access sites in patients having undergone diagnostic or interventional procedures.
The trial will encompass 400 patients from 18 medical centers across the U.S.
